145 related articles for article (PubMed ID: 37766865)
1. Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma.
Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G
Front Oncol; 2023; 13():1282120. PubMed ID: 37766865
[TBL] [Abstract][Full Text] [Related]
2. Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma.
Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G
Front Oncol; 2022; 12():834728. PubMed ID: 35425701
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas.
Mehta S; Bhimani N; Gill AJ; Samra JS; Sahni S; Mittal A
Front Oncol; 2021; 11():774861. PubMed ID: 34692555
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.
Feng Y; Yang J; Duan W; Cai Y; Liu X; Peng Y
Front Oncol; 2024; 14():1370998. PubMed ID: 38384803
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA PSMA3 Antisense RNA 1 Promotes Cell Proliferation, Migration, and Invasion in Pancreatic Ductal Adenocarcinoma Via Targeting MicroRNA-154-5p to Positively Modulate Karyopherin Subunit Alpha 4.
Bi J; Liang W; Wang Y; Tian W; Cao S; Liu P
Pancreas; 2022 Sep; 51(8):1037-1046. PubMed ID: 36607951
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.
Liu H; Xu Y; Liang K; Liu R
Front Oncol; 2021; 11():817747. PubMed ID: 35004334
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress.
Albahde MAH; Abdrakhimov B; Li GQ; Zhou X; Zhou D; Xu H; Qian H; Wang W
Front Oncol; 2024; 14():1414456. PubMed ID: 38751807
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.
Bai L; Pfeifer T; Gross W; De La Torre C; Zhao S; Liu L; Schaefer M; Herr I
Front Oncol; 2022; 12():889215. PubMed ID: 35433483
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancer.
Bai L; Pfeifer T; Gross W; De La Torre C; Zhao S; Liu L; Schaefer M; Herr I
Front Oncol; 2024; 14():1343421. PubMed ID: 38487722
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma.
Chen X; Zhou F; Ren W; Guo J; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2024; 14():1390669. PubMed ID: 38544829
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.
Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
Front Oncol; 2023; 13():1218781. PubMed ID: 37274238
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.
Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L
Front Oncol; 2024; 14():1381151. PubMed ID: 38463236
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties
Liu H; Tao H; Wang H; Yang Y; Yang R; Dai X; Ding X; Wu H; Chen S; Sun T
Front Oncol; 2022; 12():830506. PubMed ID: 35280769
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Cho WC; Duan L
Front Oncol; 2022; 12():862076. PubMed ID: 35280792
[TBL] [Abstract][Full Text] [Related]
15. Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review.
Constantin AL; Cazacu IM; Stroescu C; Copăescu C; Săftoiu A
Rom J Morphol Embryol; 2021; 62(3):671-678. PubMed ID: 35263394
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.
Chen Y; Zhu H; Wang Y; Song Y; Zhang P; Wang Z; Gao J; Li Z; Du Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033818824314. PubMed ID: 30803373
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer.
Zhao J; Chen S; Zhu L; Zhang L; Liu J; Xu D; Tian G; Jiang T
Front Oncol; 2022; 12():1052763. PubMed ID: 36303831
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to "Collision metastasis from prostate adenocarcinoma and pancreatic ductal adenocarcinoma to a lung nodule".
JRSM Open; 2024 Jun; 15(6):20542704241260194. PubMed ID: 38835356
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Development and validation of a m
Chen Y; Xia L; Peng Y; Wang G; Bi L; Xiao X; Li C; Li W
Front Oncol; 2023; 13():1309950. PubMed ID: 38023249
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma.
Van Hiep N; Sun WL; Feng PH; Lin CW; Chen KY; Luo CS; Dung LN; Van Quyet H; Wu SM; Lee KY
Front Oncol; 2022; 12():1106553. PubMed ID: 36582792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
